Diffuse Bio
A fully automated AI-based software platform for computational protein design.
HQ
San Francisco, CA, USA
N/A
N/A
Founded
2022
Company
Valuation
Contacts
Diffuse Bio is an early-stage startup from YCombinator's 2023 batch that is building a push-button software for drug design, driven by breakthroughs in generative AI. The company’s computational protein design toolkit has been informed by the team’s breakthroughs in AI protein design for the past 6 years, including the first experimental validation of AI-generated proteins and diffusion models for protein structure and sequence.
Diffuse Bio was founded in 2022 by Namrata Anand.
Diffuse Bio was founded in 2022 by Namrata Anand.
Employees
1
As of Apr 25, 2023
Total Raised to Date
$500,000
6 Months Since Last Deal
Last Deal Details
$500,000
Pre-Seed (April, 2023)
Last Valuation
Undisclosed
Company Overview
Operating Status
Active
Ownership Type(s)
Angel
Main Product(s)
Data & Analytics
Technology
AI / ML
Tags
Biotech, GenAI
Operating Model
Model Type(s)
Subscription
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise, Non-Profits
Geographic Exposure
USA
Total Customers
Pre-Revenue
Retention Range
-
Diffuse Bio - FAQ
When was Diffuse Bio founded?
Diffuse Biowas founded in 2022.
Where is Diffuse Bio’s headquarters located?
Diffuse Bio’sheadquarters is located in San Francisco, CA, USA.
How many employees does Diffuse Bio have?
Diffuse Biohas 1 employees as of April 25, 2023.
How much has Diffuse Bio raised to-date?
As of September 18, 2023,Diffuse Biohas raised a total of $0.50 million (USD) since 2022.
When was Diffuse Bio’s last funding round?
Diffuse Bio’s most recent funding round was for $0.50 million (USD) in April 2023.
How many customers does Diffuse Bio have?
Diffuse Bio is pre-revenue and does not yet report any customers.
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts